- CEO Talks
- September 16, 2025
Dr. Steven Quay, MD, PhD, CEO of Atossa Therapeutics, was recently featured on the CEO Talks series hosted by Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine.
In this interview, Dr. Quay explains Atossa’s pioneering work to move breast cancer care beyond treatment into prevention. Key topics include:
- The potential of endoxifen to lower mammographic breast density and reduce cancer risk
- Global clinical trials under the FDA’s new Project Optimus initiative
- Combination therapies using AI-driven insights to accelerate breakthroughs
- The vision of creating a “Pap smear for breast cancer” to detect and reverse disease before it begins